IRCT20190804044429N7招募中3 期
Efficacy and safety of tofacitinib on clinical improvement in hospitalized patients with COVID19: A randomized, double blind multi-centre clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Hospitalization with oxygen saturation less than 94%
- •COVID-19 diagnosis according to chest CT scan or RT-PCR
排除标准
- •lactating women
- •Severe liver failure (Child-pugh C) or liver enzymes more than 3 times normal
- •Renal failure (glomerular filtration less than 30 ml / min)
- •Chronic use of immunosuppressive drugs or corticosteroids
- •Absolute lymphocyte count less than 500 per cubic millimeter
- •Absolute neutrophil counts less than 1000 per cubic millimeter
研究者
相似试验
尚未招募
4 期
sefulness of tofacitinib in atopic dermatitisCTRI/2024/08/072026AIIMS Bhubaneswar
已完成
4 期
effectiveness of tofacitinib in moderate to severe ulcerative colitis compared to steroidCTRI/2023/09/057448Shankar Roy94
进行中（未招募）
1 期
Effect of Tofacitinib on inflammation following pancreas transplantatioIschaemia reperfusion injury and allograft pancreatitis.MedDRA version: 20.1 Level: PT Classification code 10066127 Term: Ischaemic pancreatitis System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2017-002784-18-GBClinical Trials and Research Governance20
尚未招募
Unknown
A comparison of efficacy and safety of oral tofacitinib vs methotrexate in management of moderate to severe chronic plaque psoriasisCTRI/2023/06/053443one
尚未招募
Unknown
A clinical trial to Study the effects of oral tofacitinib and azathioprine in chronic actinic dermatitisCTRI/2023/03/051181Krishna Vishwa Vidyapeeth